COVID - 19 Vaccination Update - Day 540 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 09 JUL 2022 8:13PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 198.75 Crore (1,98,75,32,165) today. More than 8 lakh (8,95,664) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10409554
	2^nd Dose	10071723
	Precaution Dose	5854133
FLWs	1^st Dose	18425539
	2^nd Dose	17637163
	Precaution Dose	10867763
Age Group 12-14 years	1^st Dose	37459201
	2^nd Dose	25102190
Age Group 15-18 years	1^st Dose	60683232
	2^nd Dose	49562085
Age Group 18-44 years	1^st Dose	558564354
	2^nd Dose	503858571
	Precaution Dose	3945115
Age Group 45-59 years	1^st Dose	203501106
	2^nd Dose	194017380
	Precaution Dose	3024944
Over 60 years	1^st Dose	127308998
	2^nd Dose	121216174
	Precaution Dose	26022940
Cumulative 1^st dose administered		1016351984
Cumulative 2^nd dose administered		921465286
Precaution Dose		49714895
Total		1987532165

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 9^th July, 2022 (540^th Day)
HCWs	1^st Dose	54
	2^nd Dose	358
	Precaution Dose	14470
FLWs	1^st Dose	116
	2^nd Dose	768
	Precaution Dose	53866
Age Group 12-14 years	1^st Dose	52459
	2^nd Dose	112399
Age Group 15-18 years	1^st Dose	16056
	2^nd Dose	44744
Age Group 18-44 years	1^st Dose	26117
	2^nd Dose	158266
	Precaution Dose	138253
Age Group 45-59 years	1^st Dose	5620
	2^nd Dose	35741
	Precaution Dose	54398
Over 60 years	1^st Dose	3816
	2^nd Dose	24496
	Precaution Dose	153667
Cumulative 1^st dose administered		104238
Cumulative 2^nd dose administered		376772
Precaution Dose		414654
Total		895664

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.